{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:16:01Z","timestamp":1771935361939,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:p>A patient with hidradenitis suppurativa developed a progressive eczematous drug reaction to bimekizumab. The eczematous dermatitis presented in a unique distribution primarily in areas of prior hidradenitis suppurativa. We discuss our management approach, which could help clinicians who are treating similar patients.<\/jats:p>","DOI":"10.1093\/ced\/llaf425","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T07:44:12Z","timestamp":1762760652000},"page":"468-469","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u2018Predictive factors for eczematous eruptions and candidiasis during anti-interleukin-17 treatment in patients with psoriasis\u2019: bimekizumab-induced spongiotic dermatitis"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-0137","authenticated-orcid":false,"given":"Ashley N","family":"Houff","sequence":"first","affiliation":[{"name":"College of Medicine, University of Central Florida , Orlando, FL ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Cohen","sequence":"additional","affiliation":[{"name":"Dermpath Diagnostics, White Plains , NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sami","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Central Florida College of Medicine , Orlando, FL ,","place":["USA"]},{"name":"Department of Medicine, Health Sciences Campus at Lake Nona , Orlando, FL ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2026022406164868500_llaf425-B1","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/ced\/llaf271","article-title":"Predictive factors for eczematous eruptions and candidiasis during anti-\u00adinterleukin-17 treatment in patients with psoriasis: a multicentre real-life \u00adexperience in Lazio region, Italy","volume":"50","author":"Caldarola","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2026022406164868500_llaf425-B2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ced.15052","article-title":"Eczematous drug eruption in patients with psoriasis under anti-interleukin-17a: does interleukin-22 play a key role?","volume":"47","author":"Megna","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2026022406164868500_llaf425-B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"Risk of paradoxical eczema in patients receiving biologics for psoriasis","volume":"160","author":"Al-Janabi","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2026022406164868500_llaf425-B4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/1346-8138.17532","article-title":"Effectiveness of long-term bimekizumab treatment and predictive factors for responders in moderate-to-severe psoriasis: a 52-week real-world study","volume":"52","author":"Hagino","year":"2025","journal-title":"J Dermatol"},{"key":"2026022406164868500_llaf425-B5","first-page":"145","article-title":"Real-world experience of bimekizumab in a cohort of 109 patients over 48 weeks and identification of predictive factors for an early super response and risk of adverse events","volume":"15","author":"Fratton","year":"2025","journal-title":"Psoriasis (Auckl)"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf425\/65250989\/llaf425.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf425\/65250989\/llaf425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf425\/65250989\/llaf425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:16:53Z","timestamp":1771931813000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/3\/468\/8317708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":5,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,7]]},"published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf425","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,7]]}}}